On 12 February 2020 the FTSE 100 hit a pre-pandemic peak of 7,534, says Tom Howard in The Times. One year and a “vaccine-fuelled” rally later and it is still more than 12% short of that level. That compares unfavourably with other major stock markets, with the MSCI World index regaining its pre-Covid levels by August.
The key issue for the FTSE is its sectoral composition, says James Coney in the same paper. The FTSE 100 is full of out-of-fashion energy businesses, banks and high street retailers. In this age of frenetic digital innovation, it has just three tech firms that comprise 0.7% of the index. Tech accounts for 30% of America’s S&P 500.
Ocado is the FTSE 100’s only real tech star, adds Howard, but London’s junior market, Aim, looks more promising, boasting the likes of Asos. The Aim index has gained more than 25% in the past year even as the blue-chips have sagged.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Global reflation should see the FTSE’s weaknesses turn into a strength, says Paul Dales of Capital Economics. Global economic recovery will bring more prosperous times for the FTSE 100’s stable of “consumer-facing, energy and financial” businesses. On a cyclically-adjusted price/earnings ratio of about 14 the index looks like a bargain compared to other developed markets and should attract growing interest. Dales thinks the index could rally more than 20% between now and the end of 2022.
-
8 of the best houses for sale with librariesThis week: the best houses for sale with libraries – from a five-storey Georgian townhouse in Bloomsbury, London, to a 15th-century property with a library in a medieval tower in Lozère, France
-
Investors pull money from UK equities as government warns of “painful” BudgetThe government’s post-election honeymoon period has been short-lived, and investors are shying away from UK equities as a result
-
Qualcomm could acquire rival Intel – but securing the deal won't be easyA tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
-
Modi’s reforms set Indian stocks on fireIndian stocks pass a new milestone, but global fund managers are holding back. Are there signs of overheating?
-
How to invest in the quiet market monthsHere's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
-
Spire Healthcare: invest in the booming demand for private healthcareSpire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
-
Are insurance companies a good investment?Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
-
Dr Martens shares slump: should you give it the boot?Over the past three years, Dr Martens has fallen out of fashion. Are the shares worth a look?
-
Google's legal challenges – could it be broken up?Google is fending off legal challenges from both the EU and the US. But would breaking it up actually work?
-
Fast-growing bargain stocks the market has missedA professional investor recommends attractive stocks to invest in. This week: Dan Higgins, portfolio manager, Majedie Investments, highlights three favourites
